This brand name is authorized in Ecuador
The drug RUBEXAL contains a combination of these active pharmaceutical ingredients (APIs):
1
Camphora
UNII N20HL7Q941 - CAMPHOR (NATURAL)
|
|
2
Benzocaine
UNII U3RSY48JW5 - BENZOCAINE
|
Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited. |
3
Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
|
|
4
Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE
|
Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
M02AX10 | Various | M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AX Other topical products for joint and muscular pain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EC | Agencia Nacional de Regulaciรณn, Control y Vigilancia Sanitaria | Identifier(s): 050005-MAN-10-07 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.